Companies
-
Reporting season quick takes
Roger Montgomery
August 30, 2024
Amid a hectic reporting week, we offer the following quick takes, highlighting the results of key, high-quality companies. continue…
by Roger Montgomery Posted in Companies, Stocks We Like.
- save this article
- POSTED IN Companies, Stocks We Like
-
Super Retail Group’s optimistic start to FY25
Roger Montgomery
August 28, 2024
Super Retail Group (ASX:SUL), the prominent Australian omnichannel retailer, reported its annual financial results for the fiscal year 2024, reflecting strong performance that was largely pre-guided, and a positive outlook for 2025. The company, which operates four key brands – Super Cheap Auto, Rebel, BCF (Boating, Camping & Fishing), and Macpac – continues to capture a significant share of the retail market in Australia. continue…
by Roger Montgomery Posted in Companies, Stocks We Like.
- save this article
- POSTED IN Companies, Stocks We Like
-
GYG exceeds FY24 forecasts, sets positive tone for FY25
Roger Montgomery
August 27, 2024
In a stellar financial performance, and in contrast to rivals, Guzman y Gomez (GYG) has significantly surpassed both its prospectus forecasts and market expectations for FY24. The fast-casual Mexican restaurant chain reported robust growth across key financial metrics, highlighting its successful strategic initiatives and strong consumer demand. continue…
by Roger Montgomery Posted in Companies, Stocks We Like.
- save this article
- POSTED IN Companies, Stocks We Like
-
An Accent on retail results
Roger Montgomery
August 27, 2024
Youth fashion retail Accent Group, (ASX:AX1) reported FY24 results that were aligned closely with the company’s 18 July trading update. Broadly speaking, the results demonstrated steady performance despite challenges. continue…
by Roger Montgomery Posted in Companies.
- save this article
- POSTED IN Companies
-
Breville brews another solid result
Roger Montgomery
August 22, 2024
Back in February, Breville Group’s (ASX:BRG) HY24 results divided the investment community. Despite improved gross margins and efficient cost control measures, revenue fell slightly short of consensus expectations, prompting some analysts to suggest the company should have engaged in more promotional (read: discounting) activity to drive sales. Of course, strategically, this can weaken a brand and its long-term value. continue…
by Roger Montgomery Posted in Companies, Small Caps.
- save this article
- POSTED IN Companies, Small Caps
-
ARB share price up as the business invests in growth
Roger Montgomery
August 21, 2024
As you know, four-wheel drive (4WD) aftermarket parts and accessories manufacturer, distributor and retailer ARB Corporation (ASX:ARB) is one of the highest A1-quality companies listed on the Australian Securities Exchange (ASX). As we have written here at the blog many times, I believe, over time, investors will transition from seeing it as being dominated by the cyclicality of its Australian business to a global, vertically integrated growth story with the U.S. ultimately generating vastly more revenue than its local operations. continue…
by Roger Montgomery Posted in Companies, Editor's Pick, Stocks We Like.
- save this article
- POSTED IN Companies, Editor's Pick, Stocks We Like
-
Pro Medicus: A decade of exceptional growth and sustained performance
Roger Montgomery
August 20, 2024
Ten years ago, radiology software company Pro Medicus (ASX:PME) was trading at just 86 cents. Yesterday, with a share price of $149, investors have seen their money grow over 17,000 per cent in a decade.
The company supplies software technology used by radiologists (who are extremely expensive for hospitals to employ) for medical diagnoses, which also renders them more efficient. continue…
by Roger Montgomery Posted in Companies, Editor's Pick.
- save this article
- POSTED IN Companies, Editor's Pick
-
CSL posts strong sales and profit growth
Roger Montgomery
August 19, 2024
Australian Securities Exchange (ASX) healthcare leader CSL (ASX:CSL) posted a robust 11 per cent rise in sales from US$13.3 billion to US$14.8 billion, with CSL’s Behring segment, that markets products like immunoglobulin derived from blood plasma, contributing over 70 per cent of total sales. The company also reported a 21.8 per cent increase in earnings before interest, tax, depreciation and amortisation (EBITDA), a 24 per cent rise in earnings before interest and taxes (EBIT) and a 15 per cent growth in net profit for 2024, after adjusting for currency fluctuations. continue…
by Roger Montgomery Posted in Companies, Stocks We Like.
- save this article
- POSTED IN Companies, Stocks We Like
-
Can the Commonwealth Bank of Australia’s share price rally continue into FY25?
Roger Montgomery
August 16, 2024
Our domestic large-cap funds have maintained an underweight position in the banks, and even though the Commonwealth Bank of Australia (ASX:CBA) was, for a time, our largest position, being underweight in the sector has cost relative performance thanks to the Commonwealth Bank of Australia’s share price rallying as much as 23 per cent year-to-date and 35 per cent last financial year. continue…
by Roger Montgomery Posted in Companies.
- save this article
- POSTED IN Companies
-
QBE Insurance: A complex but promising 1H24 performance
Roger Montgomery
August 13, 2024
QBE Insurance’s (ASX:QBE) first-half 2024 (1H24) results offer a nuanced picture. Depending on your interpretation of the performance of the American business, QBE Insurance is either off to a challenging start to the year, or long-term prospects remain optimistic, largely driven by ongoing restructuring efforts, particularly within the company’s North American segment. continue…
by Roger Montgomery Posted in Companies, Stocks We Like.
- save this article
- POSTED IN Companies, Stocks We Like